Advanced Functional Materials · 2025 · 13 citations · 125 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryPharmaceutical FormulationDrug Delivery BiomaterialsDrug Delivery SystemsMucoadhesive Drug DeliveryMucoadhesive Drug Delivery SystemsMucoadhesive Drug FormulationsMucoadhesive Oral FormulationsOral Drug Delivery FormulationsOral Drug Delivery SystemsSystemic DeliverySystemic Drug Delivery
Abstract Intraoral delivery of active pharmaceutical ingredients (API) is an attractive approach to improve their local therapeutic efficacy or to enable their systemic delivery. It offers several advantages, such as high drug concentration at the intraoral target site and rapid access to the systemic circulation due to high vascularization of the oral cavity, bypassing first‐pass metabolism. However, several limitations need to be addressed, such as the relatively short residence time of formulations applied in the oral cavity due to salivation, swallowing reflex, and tongue movement, as well as poor membrane permeability of, in particular, hydrophilic drugs. Within this review, a comprehensive summary of the latest strategies and formulation approaches in the field of intraoral drug delivery is provided, focusing on those pursued by academia and industry to overcome those challenges. An overview is provided of excipients that are generally recognized as safe (GRAS) and utilized to enhance the efficacy of intraoral drug delivery systems, such as mucoadhesive materials, enzyme inhibitors, and permeation enhancers. Innovative pharmaceutical dosage forms are outlined, covering solid, semi‐solid, and liquid delivery systems as well as aerosols. Future trends, including self‐emulsifying systems, microneedles, and in situ bioprinting, are explored, presenting new opportunities for intraoral drug delivery.
125
Mucoadhesive drug delivery systems
Ryan F. Donnelly, Rahamatullah Shaikh, Thakur Raghu Raj Singh et al. · Journal of Pharmacy And Bioallied Sciences · 2011 · 733 citations · Full text